Yubo International Biotech Limited (YBGJ)

OTCMKTS · Delayed Price · Currency is USD

0.0054

-0.0054 (-50.00%)

At close: Oct 29, 2026

Market Cap	920.27K -60.3%
Revenue (ttm)	12.35K +256.0%
Net Income	-1.06M
EPS	-0.01
Shares Out	170.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,000
Open	0.0054
Previous Close	0.0108
Day's Range	0.0054 - 0.0054
52-Week Range	0.0049 - 0.0151
Beta	0.72
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About YBGJ

Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. It also provides light application products, including respiratory atomization products; cell basidiomycetes compound dr... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

CEO Yang Wang

Employees 14

Stock Exchange OTCMKTS

Ticker Symbol YBGJ

Full Company Profile

Financial Performance

In 2025, YBGJ's revenue was $12,353, an increase of 255.99% compared to the previous year's $3,470. Losses were -$1.08 million, -39.21% less than in 2024.

Financial Statements